6.1 Primary Hemostasis, Platelet Receptors & Qualitative Platelet Disorders

Primary Hemostasis, Platelet Receptors & Qualitative Platelet Disorders

Primary hemostasis is the rapid, highly coordinated physiological response triggered by vascular endothelial injury. Its ultimate objective is the formation of an initial, friable primary platelet plug (hemostatic plug) within seconds of vessel wall disruption. This process depends on precise interactions between the injured vessel wall, subendothelial extracellular matrix macromolecules, multimeric plasma proteins, and specialized platelet surface glycoprotein receptors.

                               [ INJURY TO VESSEL WALL ]
                                           │
                   ┌───────────────────────┴───────────────────────┐
                   ▼                                               ▼
        [ LOCAL VASOCONSTRICTION ]                      [ SUBENDOTHELIAL EXPOSURE ]
      - Endothelin-1 release                          - Type I & III Collagen fibers
      - Neurogenic reflex spasm                       - Matrix-bound vWF
                   │                                               │
                   └───────────────────────┬───────────────────────┘
                                           ▼
                               [ 1. PLATELET ADHESION ]
      - vWF A1 domain binds Platelet GPIb/IX/V (Shear-dependent tethering)
      - Direct collagen binding: GP Ia/IIa (α2β1 integrin) & GP VI (Signaling)
                                           │
                                           ▼
                         [ 2. ACTIVATION & SHAPE CHANGE ]
      - PLC & PLA2 activation ──► Arachidonic Acid ──► COX-1 ──► TxA2 synthesis
      - Disc-to-sphere transition with filopodia / pseudopod extension
      - Granule exocytosis (Dense & Alpha granules via Open Canalicular System)
                                           │
                                           ▼
                             [ 3. PLATELET AGGREGATION ]
      - Inside-out signaling activates GPIIb/IIIa (αIIbβ3 integrin)
      - Conformational opening binds Divalent Fibrinogen (and vWF)
      - Inter-platelet bridging network forms [ PRIMARY HEMOSTATIC PLUG ]

---

The Four Sequential Stages of Primary Hemostasis

1. Localized Vasoconstriction

Immediately upon physical trauma or breach of the endothelial barrier, damaged endothelial cells and local smooth muscle myocytes initiate immediate, localized vasoconstriction:

• Neurogenic Reflex: Immediate sympathetic vasomotor reflex response causing transient smooth muscle contraction.
• Biochemical Mediators: Endothelial cells release endothelin-1, a potent 21-amino acid peptide vasoconstrictor. Activated platelets simultaneously secrete serotonin (5-hydroxytryptamine / 5-HT) from dense granules and generate Thromboxane $A_2$ ($TxA_2$), maintaining sustained vascular narrowing to reduce localized blood flow and shear forces at the injury site.

2. Platelet Adhesion: Receptors and Shear Dynamics

Under normal laminar blood flow, platelets circulate in an inactive, discoid state without adhering to intact, prostacyclin- ($PGI_2$) and nitric oxide- (NO) coated endothelium. When vascular integrity is breached, circulating platelets adhere to exposed subendothelial structures:

  PLASMA / LUMEN
  ─────────────────────────────────────────────────────────────────────────────
       [ Platelet Membrane ]
         │              │                 │                      │
    [GPIb/IX/V]    [GPIIb/IIIa]       [GP Ia/IIa]             [GP VI]
     (CD42b/a)      (CD41/CD61)       (α2β1 Integrin)      (Ig Superfamily)
         │              │                 │                      │
  ═══════╪══════════════╪═════════════════╪══════════════════════╪═════════════
  SUBENDOTHELIUM
         │              │                 │                      │
      [ vWF ]     [ Fibrinogen ]     [ Collagen ]           [ Collagen ]
         │         (Aggregation)     (Direct Anchor)        (PLCγ Activation)
    [ Collagen ]
  ─────────────────────────────────────────────────────────────────────────────

• High Shear Stress Adhesion (Microvasculature and Arteries): Under high shear rates ($>1,000\text{ s}^{-1}$), direct collagen-platelet binding is kinetically unfavorable. Subendothelial Type I and Type III collagen binds the A3 domain of multimeric von Willebrand Factor (vWF). Shear forces uncoil vWF, exposing its A1 domain, which binds with high affinity to the platelet surface Glycoprotein Ib/IX/V (GPIb/IX/V) complex (specifically the N-terminal globular domain of the GPIb$\alpha$ subunit, marked by CD42b). This transient tethering slows down circulating platelets ("platelet rolling").
• Direct Collagen Binding (Low Shear / Stable Arrest): Once rolling is established, direct receptors lock the platelet to collagen:
  • Glycoprotein Ia/IIa (GP Ia/IIa / Integrin $\alpha_2\beta_1$): Provides stable, non-covalent adhesion to collagen fibers.
  • Glycoprotein VI (GP VI): A 62-kDa member of the immunoglobulin superfamily coupled to the Fc receptor $\gamma$-chain ($FcR\gamma$). Collagen binding to GP VI clusters the receptor, initiating tyrosine kinase cascades via Lyn/Fyn and Syk that activate Phospholipase $C\gamma_2$ ($PLC\gamma_2$) to drive robust intracellular activation.

3. Platelet Activation, Intracellular Signaling & Granule Secretion

Engagement of GP VI, GPIb/IX/V, and soluble agonists (thrombin, ADP, $TxA_2$) triggers a rapid surge in cytosolic free ionized calcium ($Ca^{2+}$) from the dense tubular system (DTS):

• Phospholipase C (PLC) Pathway: Cleaves membrane phosphatidylinositol 4,5-bisphosphate ($PIP_2$) into inositol 1,4,5-trisphosphate ($IP_3$) and diacylglycerol (DAG). $IP_3$ mobilizes calcium from the DTS, while DAG activates protein kinase C (PKC).
• Phospholipase $A_2$ ($PLA_2$) & Arachidonic Acid Cascade: Elevated cytosolic $Ca^{2+}$ activates cytosolic $PLA_2$, which hydrolyzes membrane phospholipids to liberate free arachidonic acid. Cyclooxygenase-1 (COX-1 / Prostaglandin G/H Synthase 1) converts arachidonic acid to prostaglandin $G_2$ ($PGG_2$) and prostaglandin $H_2$ ($PGH_2$). Thromboxane synthase then converts $PGH_2$ into Thromboxane $A_2$ ($TxA_2$). $TxA_2$ diffuses across the platelet membrane to bind $G_q$-coupled thromboxane receptors ($TP\alpha/TP\beta$), amplifying calcium flux and recruiting adjacent platelets.
• Morphologic Shape Change: Rearrangement of the marginal microtubule band and actin polymerization transforms the smooth biconcave disc into a spherical cell with long, branching pseudopods (filopodia), dramatically increasing surface area and facilitating platelet-platelet contact.
• Granule Secretion: Platelet storage granules fuse with the Open Canalicular System (OCS) and plasma membrane, discharging their contents into the localized microenvironment:

4. Platelet Aggregation: The GPIIb/IIIa Fibrinogen Bridge

Platelet aggregation is the cohesion of activated platelets to one another to form the definitive primary plug:

• Conformational Activation of Integrin $\alpha_{IIb}\beta_3$ (GPIIb/IIIa): In resting platelets, GPIIb/IIIa (a heterodimer composed of CD41 and CD61, with ~80,000 copies per platelet) exists in a low-affinity, bent conformation. Inside-out signaling mediated by talin-1 and kindlin-3 binding to the cytoplasmic $\beta_3$ tail drives a rapid hinge extension into a high-affinity, open conformation.
• Divalent Fibrinogen Crosslinking: The activated GPIIb/IIIa complex exposes binding sites for the RGD (Arg-Gly-Asp) peptide motifs on the symmetrical, dimeric plasma protein fibrinogen (and vWF under high shear). In the presence of extracellular $Ca^{2+}$, each fibrinogen molecule binds two distinct GPIIb/IIIa receptors on adjacent platelets, constructing a resilient, crosslinked platelet lattice.

---

Platelet Aggregometry: Light Transmission Aggregometry (LTA)

Developed by Gustav Born, Light Transmission Aggregometry (LTA) remains the historical reference method and gold standard for evaluating qualitative platelet disorders.

                               [ LTA PRINCIPLE ]

  LIGHT SOURCE ──► [ Turbid PRP ] (Resting) ──► DETECTOR ──► Low Light Transmittance (0%)
                         │
                    + AGONIST (Stirred at 37°C)
                         ▼
  LIGHT SOURCE ──► [ Platelet Clumps + Clear Plasma ] ──► DETECTOR ──► High Light Transmittance (100%)

Principle of LTA

• Citrated blood is gently centrifuged to yield Platelet-Rich Plasma (PRP) (turbid, high optical density) and Platelet-Poor Plasma (PPP) (clear baseline blank, representing 100% light transmittance).
• PRP is maintained at $37^\circ\text{C}$ in a cuvette with continuous magnetic stirring (1,000 rpm). A specific platelet agonist is introduced, and changes in light transmittance are recorded over time:
  • Baseline: Turbid suspension transmits minimal light ($0%$ transmittance).
  • Shape Change: Initial disc-to-sphere transition produces a slight decrease in transmittance (small downward deflection).
  • Primary Wave: Agonist binds surface receptors, inducing direct GPIIb/IIIa activation and primary, reversible platelet-platelet cohesion.
  • Secondary Wave: In response to sufficient stimulation, platelets secrete endogenous dense-granule ADP and synthesize $TxA_2$, driving irreversible secondary aggregation (accompanied by full plasma clearing and maximal light transmittance).

Agonist-Specific Response Profiles

1. Adenosine Diphosphate (ADP): At low-to-moderate concentrations ($1.0\text{ to }2.5\text{ }\mu\text{mol/L}$), produces a classic biphasic curve (primary wave via $P2Y_1$, followed by secondary secretion wave via $P2Y_{12}$). At high concentrations ($>5.0\text{ }\mu\text{mol/L}$), the two waves merge into a single broad, irreversible curve.
2. Epinephrine (Adrenaline): Binds platelet $\alpha_{2A}$-adrenergic receptors ($G_z$-coupled). Produces a distinct biphasic curve with no shape change deflection. Epinephrine requires an intact cyclooxygenase pathway and granule release to achieve full aggregation.
3. Collagen: Exhibits a distinct lag phase (1 to 2 minutes) while collagen fibrils polymerize and engage GP VI receptors. Once signaling threshold is reached, it produces a single, steep, irreversible wave that is entirely dependent on endogenous $TxA_2$ synthesis and dense granule secretion.
4. Arachidonic Acid (AA): Directly provides the substrate for COX-1, bypassing surface receptor cascades. Generates a rapid, steep, single-wave aggregation curve without a lag phase.
5. Ristocetin: An antibiotic that induces agglutination (passive physical binding) rather than metabolic aggregation. Ristocetin binds plasma vWF, altering its conformation so that its A1 domain binds platelet GPIb/IX/V, even in resting, metabolically inactive, or formalin-fixed platelets.

---

Qualitative Platelet Disorders: Diagnostic Matrix